Avid Radiopharmaceuticals Competitors and Similar CompaniesClear all

Avid Radiopharmaceuticals's competitors and similar companies include KalVista Pharmaceuticals, PreventAGE Health Care, Al Seef Hospital and Intelligent Bio Solutions.

	Avid Radiopharmaceuticals Avid Radiopharmaceuticals is a company developing molecular imaging agents for chronic human diseases.	KalVista Pharmaceuticals KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).	PreventAGE Health Care PreventAGE Health Care is a company providing patients and doctors with the tools to predict and manage diabetic complications.	Al Seef Hospital Al Seef Hospital is a provider of healthcare services.	Intelligent Bio Solutions GBS (formerly known as Glucose Biosensor Systems (Greater China) Holdings) is a biosensor diagnostic technology company.
Founding Date	Founding Date 2005	Founding Date 2011	Founding Date 2012	Founding Date 2009	Founding Date N/A
Type	Type Subsidiary	Type Public	Type Private	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech diabetes medical diagnostics medical imaging	Tags Healthcare biotech diabetes medical diagnostics	Tags Healthcare biotech diabetes medical diagnostics	Tags Healthcare diabetes medical diagnostics medical imaging surgical solutions	Tags Healthcare biotech diabetes medical diagnostics
Locations	Locations Philadelphia, US HQ	Locations Porton Down, GB HQ Cambridge, US	Locations Lebanon, US HQ	Locations Salmiya, KW HQ	Locations New York, US HQ Barangaroo, AU
Employees	Employees 933% decrease	Employees 150	Employees 8	Employees 4151% increase	Employees 1623% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 523.4 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 7 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $49.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $3.1m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $3.1m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods $1.8m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $46m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit $1.2m (FY, 2025)
Net income	Net income N/A	Net income ($109.5m) (FY, 2025)	Net income N/A	Net income N/A	Net income ($10.6m) (FY, 2025)